Status:

RECRUITING

Evaluation of Chronotype and Central Sensitization in Patients With Fibromyalgia Syndrome

Lead Sponsor:

Oğuzhan Kandemir

Conditions:

Chronotype

Fibromyalgia Syndrome

Eligibility:

FEMALE

18-65 years

Brief Summary

The aim of study is to examine the chronotype preferences of patients with fibromyalgia syndrome and the relationship between central sensitization and chronotype, and to examine its relationship with...

Detailed Description

Fibromyalgia Syndrome (FMS); It is a syndrome characterized by chronic pain occurring in more than one part of the body and accompanied by fatigue, sleep disturbance, impairment in quality of life and...

Eligibility Criteria

Inclusion

  • Being diagnosed according to ACR 2016 Fibromyalgia Syndrome Diagnostic criteria Continuing complaints for at least 3 months

Exclusion

  • Neurological and Inflammatory diseases Pregnancy Malignancy

Key Trial Info

Start Date :

December 15 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 15 2024

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT06197087

Start Date

December 15 2023

End Date

December 15 2024

Last Update

January 17 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Afyonkarahisar Health Sciences University

Afyonkarahisar, Turkey (Türkiye), 03200

Evaluation of Chronotype and Central Sensitization in Patients With Fibromyalgia Syndrome | DecenTrialz